{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/raynauds-phenomenon/diagnosis/clinical-features/","result":{"pageContext":{"chapter":{"id":"509776f6-588e-5896-9432-bf45ef2f63e1","slug":"clinical-features","fullItemName":"Clinical features","depth":2,"htmlHeader":"<!-- begin field 3bb510f4-2db2-4116-be04-ff673b0f417b --><h2>When should I suspect Raynaud's phenomenon?</h2><!-- end field 3bb510f4-2db2-4116-be04-ff673b0f417b -->","summary":"","htmlStringContent":"<!-- begin item fbc50690-b63d-4122-be3b-a9db240bb984 --><!-- begin field 7ffe10b7-01f4-40ae-8b5d-1d9d0450fc6b --><ul><li><strong>Suspect Raynaud’s phenomenon in a person presenting with:</strong><ul><li>A history of clearly demarcated pallor of the digit(s), followed by at least one other colour change (cyanosis and/or erythema) — symptoms are usually precipitated by cold (or, less often, by emotion).<ul><li>Colour changes typically start at the tip of the finger and then spread downwards or to more digits.</li><li>The classical tri-phasic colour change may not always be present but blanching must occur for a diagnosis of Raynaud’s phenomenon to be made.</li><li>The colour change may be associated with other symptoms such as transient numbness of affected finger tips, paraesthesia on rewarming and discomfort.</li><li>Extremities other than the digits may be affected such as the tip of the nose, ear lobes, tongue and nipples.</li></ul></li></ul></li><li><strong>Suspect secondary Raynaud’s phenomenon if any of the following are present</strong>:<ul><li>Digital ulcers, gangrene, or severe ischaemia of one or more digits.</li><li>Onset over the age of 30 years.</li><li>Episodes that are intense, painful, or asymmetrical.</li><li>History of, or clinical features suggestive of, a connective tissue disorder (such as sclerodactyly or pitting scars on the fingertips) or <a class=\"topic-reference internal-reference\" href=\"/topics/raynauds-phenomenon/diagnosis/differential-diagnosis/\">other causes</a>  of digital vasospasm.</li><li>Positive anti-nuclear antibody tests.</li><li>Abnormal nail-fold capillaries.</li></ul></li><li><strong>Suspect primary Raynaud’s phenomenon</strong> if episodes are completely reversible and there are no features of secondary Raynaud’s phenomenon.</li></ul><!-- end field 7ffe10b7-01f4-40ae-8b5d-1d9d0450fc6b --><!-- end item fbc50690-b63d-4122-be3b-a9db240bb984 -->","topic":{"id":"255ee7a1-48e0-54c2-a732-4e03fba17a60","topicId":"e0f3a627-69e7-4258-bfd3-06ad68e3ba94","topicName":"Raynaud's phenomenon","slug":"raynauds-phenomenon","lastRevised":"Last revised in February 2020","chapters":[{"id":"0209e319-b6f4-5f73-ae5c-6afd753453ea","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"9bb70ded-aa7a-5909-9d84-111f559bccc8","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"47c14b87-688e-5e8e-af1c-e6614c461561","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"ad9e53ac-9556-5bdd-aa04-09e22fccd689","slug":"changes","fullItemName":"Changes"},{"id":"aa95064f-a6c4-5317-a6ec-33fca3665fa5","slug":"update","fullItemName":"Update"}]},{"id":"0346daa7-fb38-5512-b2c8-7f0d5d4b7c91","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"074b9165-8cc3-56b5-a9fa-483516a026aa","slug":"goals","fullItemName":"Goals"},{"id":"dadcf48d-9a98-54cf-baab-c0b65179b8f1","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"d272b294-ed60-5488-8640-d756cbe670a3","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9dcdeaed-4201-583c-a5a9-5dcb4ead9acb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"4c107602-0bb8-52d9-b277-5639494a105e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"72ac11d0-1027-5c50-ae82-9ae1e1bf92b7","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0559a1bc-62df-54ef-846b-db71b06fbe87","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2ec7ca08-f644-50e8-b54e-c6378c7053b0","slug":"definition","fullItemName":"Definition"},{"id":"951db58c-3bcb-56ef-be5f-1e0fd9fdbd81","slug":"causes-of-or-diseases-associated-with-raynauds-phenomenon","fullItemName":"Causes of, or diseases associated with Raynaud's phenomenon:"},{"id":"b9b9e063-b592-5419-8f15-8f350c8de255","slug":"prevalence-incidence","fullItemName":"Prevalence and incidence"},{"id":"16789ea7-d3e6-5c24-a51f-e9f57845b88b","slug":"prognosis","fullItemName":"Prognosis"},{"id":"b914d639-5ff2-526f-86e9-1280331ece9b","slug":"complications","fullItemName":"Complications"}]},{"id":"1478d9b3-2ba3-5103-9fab-2a67d58f88f4","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"509776f6-588e-5896-9432-bf45ef2f63e1","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"9a10980a-a167-52bd-9991-be6f6cd68c50","slug":"assessment","fullItemName":"Assessment"},{"id":"ab1aab22-cf2f-584c-b073-a5bba7ae4c6d","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"143745f3-74bd-57da-b042-3dd311837d98","fullItemName":"Management","slug":"management","subChapters":[{"id":"f6006983-20db-5702-8a8c-9763d45ab3cf","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"ede08fed-d06c-5c6c-9c34-9ada648e6c09","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"1c7cb268-2a82-5737-b0ee-332487a61ea1","slug":"nifedipine","fullItemName":"Nifedipine"}]},{"id":"f6403106-c5ec-5705-bdcf-a225c5de60f9","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"8a93fc9c-f20c-58a4-a5db-33420cd3b27a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"e2a1391d-6c3d-5d36-b072-abc59f16980c","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"bfa3b4f4-feec-59d7-9574-f36fc1bcf5cd","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"18ed7dfb-e0e7-5be9-9a57-0ab24f1666c5","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2bf5741c-d447-5f96-8155-861976265e79","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"52d565ac-2dac-556a-9bc8-c5c8946df2ed","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1b7e64ea-3359-5d63-93ff-6b661619a25e","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"1478d9b3-2ba3-5103-9fab-2a67d58f88f4","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"fb520b0d-1a67-5b2c-9b69-5f7ee9f3e292","slug":"basis-for-recommendation-85c","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field c585b079-1370-453a-88d1-cc9ae0939ccd --><h3>Basis for recommendation</h3><!-- end field c585b079-1370-453a-88d1-cc9ae0939ccd -->","summary":null,"htmlStringContent":"<!-- begin item 85cacd9d-341c-4c46-b6c4-62702b26f74e --><!-- begin field 4fdd5121-c05e-46ff-9bac-db2bcb3b3376 --><p>The information on the clinical features of Raynaud’s phenomenon (RP) are based on clinical guidelines <em>International consensus criteria for the diagnosis of Raynaud's phenomenon</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Maverakis, 2014</a>] and <em>European Society for Vascular Medicine (ESVM) guidelines - the diagnosis and management of Raynaud's</em> phenomenon [<a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Belch, 2017</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Wigley, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Herrick, 2017</a>].</p><ul><li>The classical tri-phasic colour change of Raynaud’s phenomenon is not always present — it is thought to occur in about one-third of primary Raynaud’s phenomenon patients and two thirds of secondary Raynaud’s phenomenon. Blanching must be a feature for a diagnosis of Raynaud’s phenomenon to be made [<a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Belch, 2017</a>].</li><li>The majority of cases of Raynaud’s phenomenon are primary — onset of primary Raynaud’s phenomenon is typically in the teenage years and twenties. People in their third to fifth decade who presents for the first time with Raynaud’s phenomenon are at high risk of having/developing a connective tissue disorder [<a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Wigley, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Belch, 2017</a>].</li><li>Nailfold abnormalities (including dilated vessels which are sometimes visible to the naked eye) are suggestive of an underlying connective tissue disorder. Nailfold capillaroscopy is recommended in assessment of a person with Raynaud's phenomenon in clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Hughes, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Belch, 2017</a>] and several review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Linnemann, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Ennis, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Pain, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Wigley, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Herrick, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/raynauds-phenomenon/references/\">Ingegnoli, 2017</a>] — unless expertise is available locally this is usually carried out in secondary care.</li></ul><!-- end field 4fdd5121-c05e-46ff-9bac-db2bcb3b3376 --><!-- end item 85cacd9d-341c-4c46-b6c4-62702b26f74e -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}